PTGER4 and prostate cancer: Our investigation has elucidated that the ABCC4-PGE2-EP2/EP4 signaling axis triggers downstream mitochondrial depolarization and glucose metabolic reprogramming, which serves as a crucial underlying mechanism for the functional impairment and immunosuppression of CD8+ T cells within the prostate cancer microenvironment.